Format

Send to

Choose Destination
J Thorac Dis. 2018 Nov;10(Suppl 33):S4061-S4064. doi: 10.21037/jtd.2018.09.106.

Circulating tumor DNA analysis in patients with EGFR mutant lung cancer.

Author information

1
Department of Medicine, University of California, San Francisco, CA, USA.
2
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Conflict of interest statement

Conflicts of Interest: TG Bivona is a consultant or advisory board member to Revolution Medicines, Array Biopharma, Novartis, AstraZeneca and receives research support from Revolution Medicines and Novartis. S Nanjo receives research support from AstraZeneca.

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center